PBM Reimbursement Pressure
Pharmacy Benefit Managers continue to squeeze independent pharmacy margins through DIR fees, MAC pricing, and audit clawbacks.
Start Solving This TodayIndustry Data
Pain Points
- 1Underwater reimbursements on common generics
- 2Unpredictable DIR fee reconciliation
- 3MAC pricing below acquisition cost
- 4Audit clawbacks months after dispensing
- 5Network access tied to unfavorable terms
- 6GER and performance metric penalties
Solutions
- Diversify revenue with cash-pay prescriptions
- Join prescription marketplaces for direct patient access
- Develop specialty and compounding services
- Implement cost-plus pricing transparency
- Build direct prescriber relationships
- Advocate for PBM reform legislation
Action Steps
Audit your PBM contracts for underwater medications
Identify high-volume generics with negative margins
Calculate potential cash-pay revenue opportunity
Join Script Unlock to access cash-pay patients
Develop cash pricing for your top 100 medications
Frequently Asked Questions
Why are PBMs squeezing pharmacy reimbursements?
PBMs profit from spread pricing and DIR fees, creating misaligned incentives that prioritize their margins over pharmacy sustainability. The solution is building revenue streams outside PBM control.
Can pharmacies survive without PBM contracts?
While completely exiting PBM networks is risky, diversifying with cash-pay revenue through platforms like Script Unlock reduces dependence and improves overall margins.
What is the best defense against DIR fees?
The best defense is diversification—cash-pay prescriptions have no DIR fees, making platforms like Script Unlock essential for margin protection.
How Script Unlock Helps
Script Unlock directly addresses pbm pressure by connecting your pharmacy with cash-pay patients seeking affordable medications—diversifying your revenue and reducing PBM dependence.
New Revenue
Access patients actively seeking affordable prescriptions
Pre-Qualified Leads
Patients come to you ready to buy—no cold marketing
Guaranteed Payment
No DIR fees, no clawbacks, predictable margins
Related Industry Challenges
Patient Acquisition
Finding and attracting new patients is increasingly expensive and competitive for independent pharmacies.
Read about Patient AcquisitionCash-Pay Growth
The cash-pay prescription market is growing rapidly, but many pharmacies don't know how to access these patients.
Read about Cash-Pay GrowthChain Competition
Independent pharmacies must differentiate and compete effectively against well-funded chain pharmacy competitors.
Read about Chain Competition